Baas J, Varga J, Feghali-Bostwick C, Peters-Golden M, Fortier S
bioRxiv. 2025; .
PMID: 40060695
PMC: 11888450.
DOI: 10.1101/2025.02.26.640163.
Milara J, Ribera P, Marin S, Montero P, Roger I, Cortijo J
Mol Med. 2024; 30(1):134.
PMID: 39223490
PMC: 11370283.
DOI: 10.1186/s10020-024-00906-8.
Barbarroja N, Lopez-Medina C, Escudero-Contreras A, Arias-de la Rosa I
Front Immunol. 2024; 15:1459185.
PMID: 39170613
PMC: 11335487.
DOI: 10.3389/fimmu.2024.1459185.
Lusardi M, Rapetti F, Spallarossa A, Brullo C
Int J Mol Sci. 2024; 25(15).
PMID: 39125619
PMC: 11311937.
DOI: 10.3390/ijms25158052.
Saatci O, Alam R, Huynh-Dam K, Isik A, Uner M, Belder N
Cell Death Dis. 2024; 15(6):418.
PMID: 38879508
PMC: 11180193.
DOI: 10.1038/s41419-024-06814-3.
Therapeutic perspectives on PDE4B inhibition in adipose tissue dysfunction and chronic liver injury.
Staller D, Bennett R, Mahato R
Expert Opin Ther Targets. 2024; 28(7):545-573.
PMID: 38878273
PMC: 11305103.
DOI: 10.1080/14728222.2024.2369590.
Targeting LINC00152 activates cAMP/Ca/ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer.
Saatci O, Alam R, Huynh-Dam K, Isik A, Uner M, Belder N
bioRxiv. 2024; .
PMID: 38496603
PMC: 10942410.
DOI: 10.1101/2023.11.05.565697.
A bioluminescent and homogeneous assay for monitoring GPCR-mediated cAMP modulation and PDE activity.
Mikheil D, Larsen M, Hsiao K, Murray N, Ugo T, Wang H
Sci Rep. 2024; 14(1):4440.
PMID: 38396287
PMC: 10891162.
DOI: 10.1038/s41598-024-55038-0.
Inactivation of phosphodiesterase-4B gene in rat nucleus accumbens shell by CRISPR/Cas9 or positive allosteric modulation of the protein affects the motivation to chronically self-administer nicotine.
Sharp B, Jiang Q, Kim P, Chen H
Sci Rep. 2024; 14(1):2562.
PMID: 38297069
PMC: 10831042.
DOI: 10.1038/s41598-024-53037-9.
The evolution of small molecule enzyme activators.
Dow L, Case A, Paustian M, Pinkerton B, Simeon P, Trippier P
RSC Med Chem. 2023; 14(11):2206-2230.
PMID: 37974956
PMC: 10650962.
DOI: 10.1039/d3md00399j.
Mechanical vibration patterns elicit behavioral transitions and habituation in crawling larvae.
Berne A, Zhang T, Shomar J, Ferrer A, Valdes A, Ohyama T
Elife. 2023; 12.
PMID: 37855833
PMC: 10586805.
DOI: 10.7554/eLife.69205.
Inhibition of phosphodiesterase 4D suppresses mTORC1 signaling and pancreatic cancer growth.
Jeong M, Urquhart G, Lewis C, Chi Z, Jewell J
JCI Insight. 2023; 8(13).
PMID: 37427586
PMC: 10371348.
DOI: 10.1172/jci.insight.158098.
Phosphodiesterase-4 Inhibition in Parkinson's Disease: Molecular Insights and Therapeutic Potential.
Roy D, Balasubramanian S, Krishnamurthy P, Sola P, Rymbai E
Cell Mol Neurobiol. 2023; 43(6):2713-2741.
PMID: 37074485
PMC: 11410141.
DOI: 10.1007/s10571-023-01349-1.
Genetic deletion of phosphodiesterase 4D in the liver improves kidney damage in high-fat fed mice: liver-kidney crosstalk.
Tao X, Chen C, Huang Z, Lei Y, Wang M, Wang S
Cell Death Dis. 2023; 14(4):273.
PMID: 37072403
PMC: 10113384.
DOI: 10.1038/s41419-023-05792-2.
Acute PDE4 Inhibition Induces a Transient Increase in Blood Glucose in Mice.
Irelan D, Boyd A, Fiedler E, Lochmaier P, McDonough W, Aragon I
Int J Mol Sci. 2023; 24(4).
PMID: 36834669
PMC: 9963939.
DOI: 10.3390/ijms24043260.
Non-Selective PDE4 Inhibition Induces a Rapid and Transient Decrease of Serum Potassium in Mice.
Boyd A, Lochmaier P, Irelan D, Fiedler E, Lee J, Fouty B
Biology (Basel). 2022; 11(11).
PMID: 36358283
PMC: 9687940.
DOI: 10.3390/biology11111582.
Phosphorylation, compartmentalization, and cardiac function.
Collins K, Scott J
IUBMB Life. 2022; 75(4):353-369.
PMID: 36177749
PMC: 10049969.
DOI: 10.1002/iub.2677.
Prioritizing Pesticides of Potential Concern and Identifying Potential Mixture Effects in Great Lakes Tributaries Using Passive Samplers.
Loken L, Corsi S, Alvarez D, Ankley G, Baldwin A, Blackwell B
Environ Toxicol Chem. 2022; 42(2):340-366.
PMID: 36165576
PMC: 10107608.
DOI: 10.1002/etc.5491.
An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022.
Crocetti L, Floresta G, Cilibrizzi A, Giovannoni M
Molecules. 2022; 27(15).
PMID: 35956914
PMC: 9370432.
DOI: 10.3390/molecules27154964.
Phosphodiesterase 11 A (PDE11A), a potential biomarker for glioblastoma.
Lee H, Park S, Kong G, Kwon S, Park J, Park J
Toxicol Res. 2022; 38(3):409-415.
PMID: 35874504
PMC: 9247127.
DOI: 10.1007/s43188-022-00129-1.
